ACTR707

Unum racks up yet another FDA hold as it twists its way through a restructuring, looking for a fresh start with a preclinical drug
Endpoints
Mon, 03/9/20 - 11:36 pm
Unum Therapeutics
ACTR707
B-cell non-Hodgkin lymphoma
clinical trials